MYNZ - MAINZ BIOMED N.V.

QQQ $ 482.88 $ 2.24 (0.47 %)

DIA $ 408.91 $ 0.43 (0.11 %)

SPY $ 560.81 $ 1.92 (0.34 %)

TLT $ 98.72 $ 0.06 (0.06 %)

GLD $ 232.16 $ -0.31 (-0.13 %)

Previous Close

$ 0.3556

Open

Bid

$ 0.32 x 1,000

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.31 - $ 4.38

Volume

1,571,074

Average Volume

Market Cap

7.53M

Beta (5Y Monthly)

$ 0.54

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

pfizer-records-first-sales-growth-in-its-post-covid-era-and-it-owes-it-to-cancer

Pfizer Records First Sales Growth In Its P...
07/30/2024 16:09:06

The market for vaccines and treatments used in managing COVID-19 has shrunk by billions of dollars a year. Forced to rebuild th...

Mainz Biomed Launches Improvements To Colo...
07/25/2024 12:11:03

pfizer-and-mainz-provide-examples-of-using-emerging-technology-for-good

Pfizer And Mainz Provide Examples Of Using...
07/10/2024 17:04:40

This week, Pfizer Inc (NYSE: PFE) revealed a new collaboration to unlock new therapeutic approaches. Its smaller European indus...

Mainz Biomed shares are trading higher aft...
07/09/2024 11:57:26

why-mainz-biomed-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket

Why Mainz Biomed Shares Are Trading Higher...
07/09/2024 09:33:25

Mainz Biomed Seeks FDA Breakthrough Device...
07/09/2024 07:03:47

Mainz Biomed N.V. (NASDAQ:MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, announc...

why-arhaus-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Arhaus Shares Are Trading Lower By Aro...
07/08/2024 17:16:55

mrna-technology-promises-to-make-a-long-time-coming-turning-point-in-cancer-treatment

mRNA Technology Promises To Make A Long-Ti...
07/02/2024 17:38:18

The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame duri...

Mainz Biomed Achieves Key Milestones In Fi...
07/02/2024 12:08:15

beating-cancer-is-still-an-everything-but-easy-challenge-that-pharmaceutical-companies-cannot-solve-overnight

Beating Cancer Is Still An Everything-But-...
06/26/2024 15:29:20

On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threa...

promising-trial-results-show-new-standards-in-cancer-treatment-and-diagnostics-are-on-the-horizon

Promising Trial Results Show New Standards...
06/04/2024 17:45:09

On Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed promising long-term results in a...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 12:06:42

Mainz Biomed Presents New Study Data For C...
06/03/2024 12:16:05

New study data confirmed previous ColoFuture and eAArly DETECT study performance with sensitivity for CRC of 92% and 82% for ad...

why-ooma-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket

Why Ooma Shares Are Trading Higher By Arou...
05/29/2024 12:07:38

Mainz Biomed Presents New Pooled Colorecta...
05/28/2024 12:07:08

Key Findings: 92.3% Sensitivity for Colorectal Cancer, 82.3% for Advanced Precancerous Lesions Poster presentation showing new ...

pfizer-astrazeneca-sanofi-and-mainz-biomed-to-uplevel-europes-pharma-game

Pfizer, AstraZeneca, Sanofi And Mainz Biom...
05/16/2024 12:51:36

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will...

mrna-is-promising-a-breakthrough-in-fighting-cancer

mRNA Is Promising A Breakthrough In Fighti...
04/29/2024 14:02:43

When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a...

Mainz Biomed Reports Topline Results From ...
04/25/2024 13:30:07

Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class ...

Cantor Fitzgerald Reiterates Neutral on Ma...
04/12/2024 13:58:17

Cantor Fitzgerald analyst Ross Osborn reiterates Mainz Biomed (NASDAQ:MYNZ) with a Neutral.

the-pharmaceutical-industry-finds-itself-at-a-historical-crossroads

The Pharmaceutical Industry Finds Itself A...
04/10/2024 14:47:51

Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE: